The Mount Sinai South Nassau Vaxmobile will be in New York to take on the Freeport High School on November 30, 2021.
Pfizer and BioNTech have developed a vaccine that protects against the omicron variant of the virus that causes Covid-19.
A booster shot of the vaccine increases the amount of the vaccine that protects against the immune system. A third shot shows the same fighting abilities as the two-doses of the original strain of the virus.
Pfizer CEO Albert Bourla said in a joint statement with BioNTech that protection is improved with a third dose of the vaccine.
Bourla said that a booster is the best way to prevent the spread of COVID-19.
The companies said that the two-dose vaccine showed a reduction in the ability of the immune system to fight disease. Pfizer and BioNTech are working on a vaccine that targets omicron.
The data comes after a small, preliminary lab study by South African scientists found that omicron evaded the protection provided by antibodies to a significant degree in blood samples taken from individuals fully vaccined.
According to Bourla, omicron appears to cause milder symptoms, but spreads faster and could lead to more changes in the future.
Bourla told The Wall Street Journal that he didn't think it was good news to have something that spread quickly. It will be in billions of people and there may be another one. You don't want that.
Scientists believe that omicron spreads faster, but they need more data to determine the severity of the disease caused by the variant.
Bourla said Tuesday that they would have a good understanding of what the omicron variant means for clinical manifestations by the end of the year.
This is breaking news. You can check back for updates.
